US-based medical device developer Acutus Medical, previously backed by conglomerate General Electric, has raised $26.2m in financing from undisclosed backers.
The company develops real-time 3D cardiac chamber imaging and dipole density mapping systems to identify the sources that cause cardiac arrhythmias. The funding will be used to bring its product to market.
Randy Werneth, CEO of Acuctus, said: “We are pleased to be working with top tier investors that share our passion to develop the AcQMap System but understand the importance of offering a complete portfolio of products to help physicians tailor patient treatment while being respectful of the financial pressure on healthcare systems worldwide..
“Completion of this round of financing provides us with the opportunity to expand our product portfolio in many ways and continue to innovate and validate our core product, the AcQMap System.”
Acutus raised $28m in a series B round in 2013 from GE Ventures, which acts as General Electric’s corporate venturing unit, OrbiMed Advisors, Index Ventures and Advent Life Sciences. It had previously received $6.5m across two earlier rounds.